C5A AND ITS RECEPTOR IN ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Zhao, M. -H. [1 ]
机构：
[1] Peking Univ, Hosp 1, Beijing, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP0130
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [1] Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Bruchfeld, Annette N.
    Harper, Lorraine
    Schaier, Matthias
    Venning, Michael C.
    Hamilton, Patrick
    Burst, Volker
    Grundmann, Franziska
    Jadoul, Michel
    Szombati, Istvan
    Tesar, Vladimir
    Segelmark, Marten
    Potarca, Antonia
    Schall, Thomas J.
    Bekker, Pirow
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (09): : 2756 - 2767
  • [2] The Effect on Renal Function of the Complement C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
    Merkel, Peter
    Bekker, Pirow
    Yue, Huibin
    Kelleher, Catherine
    Schall, Thomas
    Jayne, David
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis
    Jayne, David R.
    Merkel, Peter A.
    Bekker, Pirow
    Bruchfeld, Annette
    Geetha, Duvuru
    Karras, Alexandre
    Niles, John
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B1 - B1
  • [4] Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis
    Jayne, David
    Merkel, Peter
    Bruchfeld, Annette
    Geetha, Duvuru
    Karras, Alexandre
    Niles, John
    Bekker, Pirow
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4117 - 4120
  • [5] THE EFFECT OF AVACOPAN, A COMPLEMENT C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WITH RENAL DISEASE
    Jayne, David
    Merkel, Peter
    Bekker, Pirow
    McMahon, Jeffrey
    Schall, Thomas J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [6] ORAL C5A RECEPTOR ANTAGONIST CCX168 IN A PHASE 2 CLINICAL TRIAL IN ANCA-ASSOCIATED RENAL VASCULITIS
    Bekker, Pirow
    Potarca, Antonia
    Dairaghi, Daniel
    Miao, Shichang
    Powers, Jay P.
    Jaen, Juan C.
    Schall, Thomas J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 419 - 420
  • [7] The Effect of Treatment with the Complement C5a Receptor Inhibitor Avacopan on Health-Related Quality of Life in ANCA-Associated Vasculitis
    Strand, Vibeke
    Bekker, Pirow
    Yue, Huibin
    Jayne, David R. W.
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1990 - 1992
  • [8] PHASE 2 RANDOMISED TRIAL OF ORAL C5A RECEPTOR ANTAGONIST CCX168 IN ANCA-ASSOCIATED RENAL VASCULITIS
    Jayne, David R. W.
    Bruchfeld, Annette
    Schaier, Matthias
    Ciechanowski, Kazimierz
    Harper, Lorraine
    Jadoul, Michel
    Segelmark, Marten
    Selga, Daina
    Szombati, Istvan
    Venning, Michael
    Hamilton, Patrick
    Hugo, Christian
    Van Daele, Paul L. A.
    Viklicky, Ondrej
    Potarca, Antonia
    Schall, Thomas J.
    Bekker, Pirow
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 27 - 27
  • [9] ORAL C5A RECEPTOR ANTAGONIST CCX168 PHASE 2 CLINICAL TRIAL IN ANCA-ASSOCIATED RENAL VASCULITIS
    Jayne, D. R.
    Bruchfeld, A.
    Schaier, M.
    Ciechanowski, K.
    Harper, L.
    Jadoul, M.
    Segelmark, M.
    Selga, D.
    Szombati, I.
    Venning, M.
    Hugo, C.
    Van Daele, P. L.
    Viklicky, O.
    Potarca, A.
    Schall, T. J.
    Bekker, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 148 - 148
  • [10] ANCA-associated vasculitis
    Herrera-Darias, Sandro
    Guillen-Chirinos, Gilsy
    Gomez-Cerquera, Juan Manuel
    MEDICINA CLINICA, 2023, 160 (10): : 467 - 467
12345